Sinocelltech Group Financials
| 688520 Stock | 38.75 0.61 1.55% |
Sinocelltech | Select Account or Indicator |
Understanding current and past Sinocelltech Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sinocelltech Group's financial statements are interrelated, with each one affecting the others. For example, an increase in Sinocelltech Group's assets may result in an increase in income on the income statement.
Please note, the presentation of Sinocelltech Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sinocelltech Group's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sinocelltech Group's management manipulating its earnings.
Sinocelltech Group Stock Summary
Sinocelltech Group competes with GRG Banking, Beijing Jiaman, Beingmate Baby, Jiajia Food, and Jiangxi Sunshine. Sinocelltech Group is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100003ZL3 |
| Business Address | No 31 Kechuang |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.sinocelltech.com |
| Phone | 86 10 5862 8298 |
You should never invest in Sinocelltech Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sinocelltech Stock, because this is throwing your money away. Analyzing the key information contained in Sinocelltech Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sinocelltech Group Key Financial Ratios
Sinocelltech Group's financial ratios allow both analysts and investors to convert raw data from Sinocelltech Group's financial statements into concise, actionable information that can be used to evaluate the performance of Sinocelltech Group over time and compare it to other companies across industries.| Revenue | 1.89 B | ||||
| Gross Profit | 2.51 B | ||||
| EBITDA | 662.86 M | ||||
| Net Income | (396.02 M) | ||||
| Total Asset | 2.72 B |
Sinocelltech Group Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 1.7B | 1.4B | 2.7B | 2.7B | 3.1B | 2.1B | |
| Retained Earnings | (2.1B) | (3.0B) | (3.5B) | (3.9B) | (3.5B) | (3.7B) | |
| Accounts Payable | 139.5M | 134.6M | 188.7M | 115.9M | 133.2M | 151.5M | |
| Cash | 950.3M | 349.5M | 971.9M | 293.4M | 337.4M | 600.3M | |
| Long Term Debt | 390.6M | 697.0M | 730.0M | 1.0B | 1.2B | 690.2M | |
| Inventory | 39.2M | 89.8M | 191.9M | 202.7M | 233.1M | 125.0M | |
| Other Current Assets | 6.3M | 17.9M | 19.4M | 9.6M | 11.0M | 13.6M | |
| Total Liab | 1.1B | 1.6B | 3.0B | 3.3B | 3.8B | 2.2B | |
| Net Invested Capital | 1.1B | 751.6M | 1.4B | 1.4B | 1.6B | 1.1B | |
| Short Long Term Debt | 138.7M | 281.1M | 916.3M | 1.0B | 1.2B | 1.2B | |
| Total Current Assets | 1.0B | 590.5M | 1.5B | 1.1B | 1.2B | 974.1M | |
| Net Working Capital | 568.7M | (77.0M) | 159.3M | (966.1M) | (869.5M) | (826.0M) | |
| Intangible Assets | 31.2M | 34.7M | 122.0M | 188.1M | 216.3M | 227.1M |
Sinocelltech Group Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Interest Income | (14.6M) | (29.2M) | (81.0M) | (104.7M) | (94.2M) | (89.5M) | |
| Interest Income | 3.6M | 4.7M | 3.6M | 7.0M | 8.1M | 4.2M | |
| Interest Expense | 18.0M | 33.7M | 84.5M | 111.5M | 128.2M | 134.7M | |
| Total Revenue | 328.2K | 134.4M | 1.0B | 1.9B | 2.2B | 2.3B | |
| Gross Profit | 268.9K | 127.4M | 989.3M | 1.8B | 2.1B | 2.2B | |
| Operating Income | (709.3M) | (836.9M) | (272.7M) | 155.5M | 178.9M | 187.8M | |
| Research Development | 610.3M | 732.7M | 886.0M | 1.1B | 1.3B | 856.5M | |
| Cost Of Revenue | 59.3K | 7.0M | 33.9M | 54.5M | 62.7M | 65.9M | |
| Income Before Tax | (714.1M) | (868.9M) | (520.1M) | (396.8M) | (456.4M) | (479.2M) | |
| Net Income | (712.5M) | (866.9M) | (519.0M) | (396.0M) | (455.4M) | (478.2M) | |
| Minority Interest | 1.6M | 2.0M | 1.1M | 812.8K | 731.5K | 1.4M |
Sinocelltech Group Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Sinocelltech Group. It measures of how well Sinocelltech is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Sinocelltech Group brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Sinocelltech had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Sinocelltech Group has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 5.2M | (50.6M) | (102.1M) | (53.1M) | (47.8M) | (50.2M) | |
| Investments | (106.9M) | (183.7M) | (548.5M) | (502.8M) | (452.5M) | (429.9M) | |
| Change In Cash | 786.5M | (600.8M) | 621.6M | (677.7M) | (609.9M) | (579.4M) | |
| Free Cash Flow | (654.7M) | (1.1B) | (982.7M) | (888.7M) | (799.9M) | (839.9M) | |
| Change In Working Capital | 105.9M | (100.0M) | (66.5M) | (259.9M) | (233.9M) | (222.2M) | |
| Begin Period Cash Flow | 163.8M | 950.3M | 349.5M | 971.1M | 1.1B | 1.2B | |
| Depreciation | 40.0M | 52.3M | 66.0M | 114.9M | 132.1M | 68.0M | |
| Other Non Cash Items | 19.0M | 34.3M | 88.1M | 127.2M | 146.3M | 153.6M | |
| Dividends Paid | 23.0M | 32.3M | 84.5M | 117.2M | 134.7M | 141.5M | |
| Capital Expenditures | 117.3M | 193.9M | 554.8M | 505.4M | 581.2M | 329.9M | |
| Total Cash From Operating Activities | (537.4M) | (862.8M) | (427.9M) | (383.4M) | (440.9M) | (462.9M) | |
| Net Income | (712.5M) | (866.9M) | (519.0M) | (396.0M) | (455.4M) | (478.2M) | |
| End Period Cash Flow | 950.3M | 349.5M | 971.1M | 293.4M | 337.4M | 600.2M |
Sinocelltech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sinocelltech Group's current stock value. Our valuation model uses many indicators to compare Sinocelltech Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sinocelltech Group competition to find correlations between indicators driving Sinocelltech Group's intrinsic value. More Info.Sinocelltech Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sinocelltech Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sinocelltech Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sinocelltech Group Systematic Risk
Sinocelltech Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sinocelltech Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Sinocelltech Group correlated with the market. If Beta is less than 0 Sinocelltech Group generally moves in the opposite direction as compared to the market. If Sinocelltech Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sinocelltech Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sinocelltech Group is generally in the same direction as the market. If Beta > 1 Sinocelltech Group moves generally in the same direction as, but more than the movement of the benchmark.
Sinocelltech Group Total Assets Over Time
Sinocelltech Group Thematic Clasifications
Sinocelltech Group is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Sinocelltech Group March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sinocelltech Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sinocelltech Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sinocelltech Group based on widely used predictive technical indicators. In general, we focus on analyzing Sinocelltech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sinocelltech Group's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.81 | |||
| Information Ratio | 0.0366 | |||
| Maximum Drawdown | 9.22 | |||
| Value At Risk | (2.62) | |||
| Potential Upside | 3.11 |
Complementary Tools for Sinocelltech Stock analysis
When running Sinocelltech Group's price analysis, check to measure Sinocelltech Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinocelltech Group is operating at the current time. Most of Sinocelltech Group's value examination focuses on studying past and present price action to predict the probability of Sinocelltech Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinocelltech Group's price. Additionally, you may evaluate how the addition of Sinocelltech Group to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |